Posted by Thornton Law Firm LLP on Oct 25, 2013 4:30:00 AM Long before smartphone applications were sold with the catchphrase “There’s an app for that,” the notion of a cure-all for any situation has always been the province of chemicals. More than ever, we are...
A second DePuy ASR hip implant case scheduled for trial this month has been resolved, according to court records. The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.
The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.
Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit before trial. The case would have been the first “bellwether” trial in a California state court consolidation of ASR cases. The Plaintiff, Mr. Robert Eugene Ottman, was set to begin presenting his case in two weeks in state court in San Francisco.
By David C. Strouss, Esq. Posted on Oct 2, 2013 Overshadowed by the continuing debate over the government shutdown is the apparent fate of legislative protection of companies responsible for genetically modified organisms (“GMO”). In March of this year, a last-minute...
By Michael A. Lesser, Esq. Posted on Oct 2, 2013 The Securities and Exchange Commission (“SEC”) just announced an award of more than $14 million to a single whistleblower whose information led to an SEC enforcement action that recovered substantial investor...
By Michael A. Lesser, Esq. Posted on Sep 25, 2013 Dr. Frances Oldham Kelsey Released in Germany in 1957 as an all-purpose sedative, but later widely used as a preventative treatment for “morning sickness,”...
As a result of the widespread use of their deadly products, many of the manufacturers of asbestos-containing products have filed for Chapter 11 bankruptcy protection. After filing for bankruptcy, our laws protect asbestos companies from further individual lawsuits filed by people with mesothelioma or other asbestos-related disease. But before an asbestos company can reorganize and emerge from bankruptcy, courts require them to pay compensation for those injured by the company’s products and conduct. Part of the bankruptcy process, therefore, involves the company setting aside a specific amount of funds in order to pay the claims of all injured individuals. The sum of money set aside by the company, under court supervision, is referred to as a “bankruptcy trust.” Once the trust is established, it is the only way for victims injured by that company’s products to receive compensation from that company. The company can no longer be sued.
By David C. Strouss, Esq. Posted on Sep 23, 2013 Earlier this month, the FDA announced that it will require all extended-release and long-acting opioid analgesics intended to treat pain such as Percocet, Vicodin, Oxycontin, and others to have a new warning label....
By: Andrew S. Wainwright, Esq., Sep 19, 2013 3:47:00 PM A person who has been exposed to (breathed in) asbestos may be at risk for several diseases. It is not necessary to have worked directly with asbestos to have breathed it in. The primary health risks of asbestos...
Thornton Law Firm currently represents over 100 children with one of the most devastating types of birth defects, neural tube defects, arising from exposure to toxic chemicals and other hazardous substances. Neural tube defects are disorders of the central nervous system and involve such conditions as spina bifida (incomplete development of the spine), anencephaly (the skull does not close completely and part of the brain may be missing), and encephalocele (the brain is pushed through an opening in the skull).
When Ronald “Ron” Motley passed on August 22, 2013, not only did the legal world lose one of its brightest and most ferocious lights, those most in need of representation and justice lost one of their greatest champions.
The first DePuy ASR bellwether trial over Johnson & Johnson DePuy Unit’s hip implants, scheduled to begin today, September 9th in the consolidated federal Multi-District Litigation, has been adjourned for two weeks.